Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
Chimeric antigen receptor T cells (CAR-T cells) therapy has been well recognized for treating B cell-derived malignancy. However, the efficacy of CAR-T cells against solid tumors remains dissatisfactory, parti...
8:19
Biomarker Research 2020
No hay comentarios:
Publicar un comentario